Oncorus Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
64
- Latest Deal Type
-
Liquidation
Oncorus General Information
Description
Oncorus Inc is a preclinical-stage biopharmaceutical company focused on the intravenous administration of self-amplifying RNA to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-021 and ONCR-788 which are based on coxsackievirus A21 or CVA21, and Seneca Valley Virus, or SVV, respectively.
Contact Information
Website
www.oncorus.comCorporate Office
- 4 Corporate Drive
- Andover, MA 01810
- United States
Corporate Office
- 4 Corporate Drive
- Andover, MA 01810
- United States
Oncorus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 01-Jun-2023 | Completed | Bankruptcy: Liquidation | |||
| 5. 2PO | 12-Feb-2021 | Completed | Generating Revenue | |||
| 4. IPO | 02-Oct-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 20-Dec-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 15-Dec-2016 | $23.8M | $61M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | 19-Jul-2016 | $37.2M | $37.2M | Completed | Generating Revenue |
Oncorus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 |
Oncorus Comparisons
Industry
Financing
Details
Oncorus Competitors (97)
One of Oncorus’s 97 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
| Genelux | Formerly VC-backed | Westlake Village, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| Corbus Pharmaceuticals Holdings | Formerly VC-backed | Norwood, MA |
Oncorus Patents
Oncorus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023212685-A2 | Production of rna polynucleotides encoding picornavirus | Inactive | 29-Apr-2022 | ||
| WO-2023107878-A1 | Compositions and methods of seneca valley virus (svv) related cancer therapy | Inactive | 06-Dec-2021 | ||
| WO-2023034867-A1 | Engineered oncolytic herpesviruses | Inactive | 31-Aug-2021 | ||
| WO-2022173531-A1 | Compounds, compositions, and methods of using thereof | Inactive | 10-Feb-2021 | ||
| WO-2022173531-A9 | Compounds, compositions, and methods of using thereof | Inactive | 10-Feb-2021 | C12N15/88 |
Oncorus Signals
Oncorus ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Oncorus Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Oncorus Securities Corporation | Foxboro, MA |
Oncorus FAQs
-
When was Oncorus founded?
Oncorus was founded in 2015.
-
Where is Oncorus headquartered?
Oncorus is headquartered in Andover, MA.
-
What is the size of Oncorus?
Oncorus has 64 total employees.
-
What industry is Oncorus in?
Oncorus’s primary industry is Drug Discovery.
-
Is Oncorus a private or public company?
Oncorus is a Private company.
-
What is Oncorus’s current revenue?
The current revenue for Oncorus is .
-
How much funding has Oncorus raised over time?
Oncorus has raised $295M.
-
Who are Oncorus’s competitors?
Iovance Biotherapeutics, Genelux, Adaptimmune Therapeutics, Xenetic Biosciences, and Corbus Pharmaceuticals Holdings are some of the 97 competitors of Oncorus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process